Miami

Epidemiological Brief

As of 27 July 2026, Miami is classified at MEDIUM epidemic risk (composite score 34.2). Influenza-like illness (ILI) is the dominant driver at 13.3% prevalence — already 53% of the historical seasonal peak — in an atypical midsummer pattern that warrants heightened surveillance. Dengue is an active concern at 0.53 cases per 100,000 (70% of the reference maximum), underscored by Miami's established local Aedes aegypti transmission capacity. COVID-19 activity is moderate at 0.96 cases per 100,000. Pertussis incidence stands at 1.36 cases per 100,000, measles activity is low at 0.03 cases per 100,000, and mpox is detected at 0.02 cases per 100,000. Wastewater-based epidemiology (ATCP-73RE) is actively monitoring COVID-19 and influenza signals. International arrivals are the highest among all host cities at 15,525, substantially amplifying multi-pathogen importation risk. Hot and humid conditions (28 °C, 84% humidity, 6.2 mm precipitation) are conducive to both respiratory illness crowding and Aedes mosquito breeding. Priority actions include strengthening vector control at all venues, issuing traveller dengue prevention advisories, maintaining rapid influenza testing at fan medical posts, upholding isolation capacity for febrile travellers, and ensuring vaccine verification screening at all high-traffic international entry points.

Model SCEME v3.1 · Updated July 27, 2026

Please consult a local doctor or pharmacist for guidance and medication.